Dr. Redelman-Sidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2008 - 2011
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2008
Tel Aviv University SacklerClass of 2000
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2007 - 2026
NJ State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 70 citationsIFN-γ Release Assays in the Diagnosis of Latent Tuberculosis Infection among Immunocompromised AdultsGil Redelman-Sidi, Kent A. Sepkowitz
American Journal of Respiratory and Critical Care Medicine. 2013-08-15 - 464 citationsThe mechanism of action of BCG therapy for bladder cancer—a current perspectiveGil Redelman-Sidi, Michael S. Glickman, Bernard H. Bochner
Nature Reviews. Urology. 2014-03-01 - 47 citationsInfections due to dysregulated immunity: an emerging complication of cancer immunotherapyTommaso Morelli, Kohei Fujita, Gil Redelman-Sidi, Paul T. Elkington
Thorax. 2021-10-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
